TV News LIES

Friday, Sep 04th

Last update07:09:41 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Study: Pollution, weather linked to post-heart attack health

Pollution and heart attacksResearchers presenting at this year's European Society of Cardiology Congress have connected patient status after experiencing...

Planned Parenthood sues Louisiana over cut to Medicaid funds

Planned parenthoodPlanned Parenthood asked a federal judge Tuesday to stop Gov. Bobby Jindal's administration from ending Medicaid...

Undercover Planned Parenthood Videos Were Altered, Analysis Finds

Planned parenthood videos alteredPlanned Parenthood on Thursday gave congressional leaders and a committee that is investigating allegations of criminality...

Ohio bill would ban abortion for Down syndrome

ohio bill abortion for Down's syndromeOpening a new front in the abortion wars, abortion opponents are pushing Ohio to make it...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!